Muna Bhanji's Insider Trades & SAST Disclosures
Muna Bhanji's most recent trade in Cytokinetics Inc was a trade of 1,454 Common Stock done at an average price of $29.7 . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Muna Bhanji.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytokinetics Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 29.73 per share. | 15 May 2025 | 1,454 | 23,510 (0%) | 0% | 29.7 | 43,227 | Common Stock |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 10,880 | 10,880 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 7,333 | 24,964 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 29 Apr 2025 | 265 | 19,203 (0%) | 0% | 8.5 | 2,253 | Common Stock |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 9.97 per share. | 29 Jan 2025 | 265 | 19,468 (0%) | 0% | 10.0 | 2,642 | Common Stock |
| Ardelyx Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 40,243 | 40,243 | - | - | Stock Option (Right to Buy) | |
| Veracyte Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,473 | 34,578 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 11,515 | 11,515 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 7,737 | 19,733 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 20.32 per share. | 10 Jun 2024 | 3,870 | 23,105 (0%) | 0% | 20.3 | 78,634 | Common Stock |
| Cytokinetics Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 52.07 per share. | 10 Jun 2024 | 2,000 | 17,631 (0%) | 0% | 52.1 | 104,140 | Common Stock |
| Veracyte Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 28 May 2024 | 1,539 | 26,975 (0%) | 0% | 21 | 32,319 | Common Stock |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 5,600 | 19,631 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 3,636 | 3,636 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 42.33 per share. | 31 Jul 2023 | 265 | 12,261 (0%) | 0% | 42.3 | 11,217 | Common Stock |
| Cytokinetics Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 34.12 per share. | 07 Jul 2023 | 2,000 | 14,031 (0%) | 0% | 34.1 | 68,235 | Common Stock |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 39.30 per share. | 06 Jul 2023 | 1,867 | 12,526 (0%) | 0% | 39.3 | 73,373 | Common Stock |
| Veracyte Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 26.42 per share. | 16 Jun 2023 | 5,793 | 28,614 (0%) | 0% | 26.4 | 153,077 | Common Stock |
| Veracyte Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 27.09 per share. | 16 Jun 2023 | 100 | 28,514 (0%) | 0% | 27.1 | 2,709 | Common Stock |
| Ardelyx Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 49,237 | 49,237 | - | - | Stock Option (Right to Buy) | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,473 | 6,473 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,425 | 14,393 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 9,674 | 34,407 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Muna Bhanji | Director | Sale of securities on an exchange or to another person at price $ 25.91 per share. | 30 May 2023 | 1,539 | 24,733 (0%) | 0% | 25.9 | 39,875 | Common Stock |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 5,000 | 16,031 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 51.11 per share. | 03 Oct 2022 | 220 | 11,031 (0%) | 0% | 51.1 | 11,244 | Common Stock |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 41.00 per share. | 01 Jul 2022 | 274 | 10,811 (0%) | 0% | 41 | 11,234 | Common Stock |
| Veracyte Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 14,731 | 26,272 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 95,802 | 95,802 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 2,980 | 2,980 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 2,014 | 9,968 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 11,700 | 11,700 | - | - | Stock Option (Right to Buy) | |
| Intellia Therapeutics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 7,954 | 7,954 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 38.38 per share. | 01 Apr 2022 | 293 | 5,537 (0%) | 0% | 38.4 | 11,245 | Common Stock |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 46.00 per share. | 03 Jan 2022 | 244 | 5,244 (0%) | 0% | 46 | 11,224 | Common Stock |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 11,541 | 11,541 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 63,687 | 63,687 | - | - | Stock Option (Right to Buy) | |
| Cytokinetics Inc | Muna Bhanji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 35,000 | 35,000 | - | - | Non-Qualified Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges